Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Biomaterials Advances
|
May 8, 2022
Cationic inhalable particles for enhanced drug delivery to M. tuberculosis infected macrophages
Pallavi Raj Sharma, Ameya Atul Dravid, Yeswanth Chakravarthy Kalapala, et al.
Transplantation and Cellular Therapy
|
February 5, 2022
Impact of Human T Cell Lymphotropic Virus Type 1 and 2 Infection on Survival Following Stem Cell Transplantation
Vishal K Gupta, Areej El-Jawahri, Grigori Orkev, et al.
Journal of the American Geriatrics Society
|
June 17, 2016
Disparities in Age-Associated Cognitive Decline Between African-American and Caucasian Populations: The Roles of Health Literacy and Education
Vishal K Gupta, Michael Winter, Howard Cabral, et al.
Advanced Healthcare Materials
|
April 24, 2024
3D Hydrogel Culture System Recapitulates Key Tuberculosis Phenotypes and Demonstrates Pyrazinamide Efficacy
Vishal K Gupta, Vijaya V Vaishnavi, Mario L Arrieta-Ortiz, et al.
Biorxiv : the Preprint Server for Biology
|
February 9, 2026
Bidirectional fibrogenic cross-talk revealed in a human iPSC-derived epithelial-mesenchymal co-culture model of pulmonary fibrosis
Andrea B Alber, George Kwong, Vishal K Gupta, et al.
Blood Advances
|
May 7, 2025
Outcomes of Brexucabtagene Autoleucel in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients with CNS Involvement
Ibrahim N Muhsen, Gregory W Roloff, Rawan G Faramand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, et al.
Blood Advances
|
August 2, 2024
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL
Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand, et al.
Bone Marrow Transplantation
|
August 23, 2025
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia
Timothy E O'Connor, Chenyu Lin, Gregory W Roloff, et al.
Blood
|
February 5, 2026
Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene
Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Biomaterials Advances
|
May 8, 2022
Cationic inhalable particles for enhanced drug delivery to M. tuberculosis infected macrophages
Pallavi Raj Sharma, Ameya Atul Dravid, Yeswanth Chakravarthy Kalapala, et al.
Transplantation and Cellular Therapy
|
February 5, 2022
Impact of Human T Cell Lymphotropic Virus Type 1 and 2 Infection on Survival Following Stem Cell Transplantation
Vishal K Gupta, Areej El-Jawahri, Grigori Orkev, et al.
Journal of the American Geriatrics Society
|
June 17, 2016
Disparities in Age-Associated Cognitive Decline Between African-American and Caucasian Populations: The Roles of Health Literacy and Education
Vishal K Gupta, Michael Winter, Howard Cabral, et al.
Advanced Healthcare Materials
|
April 24, 2024
3D Hydrogel Culture System Recapitulates Key Tuberculosis Phenotypes and Demonstrates Pyrazinamide Efficacy
Vishal K Gupta, Vijaya V Vaishnavi, Mario L Arrieta-Ortiz, et al.
Biorxiv : the Preprint Server for Biology
|
February 9, 2026
Bidirectional fibrogenic cross-talk revealed in a human iPSC-derived epithelial-mesenchymal co-culture model of pulmonary fibrosis
Andrea B Alber, George Kwong, Vishal K Gupta, et al.
Blood Advances
|
May 7, 2025
Outcomes of Brexucabtagene Autoleucel in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients with CNS Involvement
Ibrahim N Muhsen, Gregory W Roloff, Rawan G Faramand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, et al.
Blood Advances
|
August 2, 2024
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL
Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand, et al.
Bone Marrow Transplantation
|
August 23, 2025
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia
Timothy E O'Connor, Chenyu Lin, Gregory W Roloff, et al.
Blood
|
February 5, 2026
Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene
Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang, et al.
Page
of 2